Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.
Zebrafish imaging sheds light on human neurological conditions.
The Novartis Business Development and Licensing team is behind many of the partnerships that fuel our innovation.
A pair of exceptionally large proteins provide the framework for synaptic connections.
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.